Springworks Therapeutics Inc (SWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 82,852 | 77,699 | 78,454 | 71,740 | 69,011 |
| Operating Income | -82,852 | -77,699 | -78,454 | -71,740 | -69,011 |
| Other Income | 4,927 | 4,279 | 4,276 | -648 | -39 |
| Pre-tax Income | -77,925 | -73,420 | -74,178 | -72,388 | -69,050 |
| Net Income Continuous | -77,925 | -73,420 | -74,178 | -72,388 | -69,050 |
| Net Income | $-77,925 | $-73,420 | $-74,178 | $-72,388 | $-69,050 |
| EPS Basic Total Ops | -1.25 | -1.18 | -1.17 | -1.37 | -1.41 |
| EPS Basic Continuous Ops | -1.25 | -1.18 | -1.17 | -1.37 | -1.41 |
| EPS Diluted Total Ops | -1.25 | -1.18 | -1.17 | -1.37 | -1.41 |
| EPS Diluted Continuous Ops | -1.25 | -1.18 | -1.17 | -1.37 | -1.41 |
| EPS Diluted Before Non-Recurring Items | -1.25 | -1.18 | -1.19 | -1.37 | N/A |
| EBITDA(a) | $-82,470 | $-77,446 | $-78,199 | $-71,528 | $-68,821 |